HRP20050465A2 - Carbamic acid esters with an anticholinergic action - Google Patents

Carbamic acid esters with an anticholinergic action

Info

Publication number
HRP20050465A2
HRP20050465A2 HR20050465A HRP20050465A HRP20050465A2 HR P20050465 A2 HRP20050465 A2 HR P20050465A2 HR 20050465 A HR20050465 A HR 20050465A HR P20050465 A HRP20050465 A HR P20050465A HR P20050465 A2 HRP20050465 A2 HR P20050465A2
Authority
HR
Croatia
Prior art keywords
carbamic acid
acid esters
anticholinergic action
anticholinergic
action
Prior art date
Application number
HR20050465A
Other languages
English (en)
Croatian (hr)
Inventor
Grauert Matthias
Hoffmann Matthias
Michael
Speck Georg
Breitfelder Steffen
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Publication of HRP20050465A2 publication Critical patent/HRP20050465A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20050465A 2002-11-26 2005-05-25 Carbamic acid esters with an anticholinergic action HRP20050465A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255040A DE10255040A1 (de) 2002-11-26 2002-11-26 Neue Carbaminsäureester mit anticholinerger Wirksamkeit
PCT/EP2003/012912 WO2004048373A1 (fr) 2002-11-26 2003-11-19 Esters d'acide carbamique a action anticholinergique

Publications (1)

Publication Number Publication Date
HRP20050465A2 true HRP20050465A2 (en) 2006-10-31

Family

ID=32240420

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050465A HRP20050465A2 (en) 2002-11-26 2005-05-25 Carbamic acid esters with an anticholinergic action

Country Status (20)

Country Link
EP (1) EP1567526B1 (fr)
JP (1) JP4754829B2 (fr)
KR (1) KR20050086821A (fr)
CN (1) CN1717408A (fr)
AT (1) ATE392424T1 (fr)
AU (1) AU2003289880A1 (fr)
BR (1) BR0316549A (fr)
CA (1) CA2507110C (fr)
DE (2) DE10255040A1 (fr)
EA (1) EA200500775A1 (fr)
EC (1) ECSP055803A (fr)
ES (1) ES2304538T3 (fr)
HR (1) HRP20050465A2 (fr)
MX (1) MXPA05005443A (fr)
NO (1) NO20053089D0 (fr)
PL (1) PL376638A1 (fr)
RS (1) RS20050384A (fr)
UA (1) UA81649C2 (fr)
WO (1) WO2004048373A1 (fr)
ZA (1) ZA200502946B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1626970B1 (fr) 2003-05-28 2009-07-08 Theravance, Inc. Composes d'azabicycloalcane utilises en tant qu'antagonistes des recepteurs muscariniques
TW200534855A (en) * 2004-01-13 2005-11-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
JP2008505118A (ja) * 2004-06-30 2008-02-21 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
EP1827439A4 (fr) * 2004-11-15 2009-11-18 Glaxo Group Ltd Nouveaux antagonistes du recepteur d'acetylcholine muscarinique m3
EP1904446A2 (fr) * 2005-07-11 2008-04-02 Ranbaxy Laboratories Limited Antagonistes des recepteurs muscariniques
US20090182033A1 (en) * 2005-12-16 2009-07-16 Argenta Discovery Ltd. Cyclic Amine Derivatives and Their Uses
CN101605784B (zh) 2007-02-09 2013-04-10 安斯泰来制药株式会社 氮杂桥环化合物
NZ762856A (en) 2017-10-05 2020-07-31 Fulcrum Therapeutics Inc P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
EP3710483A4 (fr) 2017-11-16 2021-10-20 XL-protein GmbH Protéines de fusion vegfr/pdgfr pasylées et leur utilisation en thérapie
EP3720852A1 (fr) * 2017-12-04 2020-10-14 Friedrich-Alexander-Universität Erlangen-Nürnberg Ligands des récepteurs muscariniques à substitution fluorophényle ayant une sélectivité pour m3 sur m2
KR20220001259A (ko) 2020-06-29 2022-01-05 (주)아모레퍼시픽 표면처리된 무기입자, 이의 제조방법, 이의 분산액 및 이를 포함하는 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759460A (fr) * 1969-11-26 1971-05-26 Knoll Ag Nouveaux carbamates et leur procede de preparation
GB8600978D0 (en) * 1986-01-16 1986-02-19 Beecham Group Plc Compounds
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
HUT76289A (en) * 1994-02-10 1997-07-28 Yamanouchi Pharma Co Ltd Carbamate derivative and medicinal composition containing the same
WO1997034892A1 (fr) * 1996-03-20 1997-09-25 Wake Forest University Recepteurs sigma-2 utilises en tant que biomarqueurs de la proliferation des cellules tumorales

Also Published As

Publication number Publication date
RS20050384A (en) 2007-12-31
NO20053089L (no) 2005-06-23
EA200500775A1 (ru) 2005-12-29
JP2006514010A (ja) 2006-04-27
UA81649C2 (ru) 2008-01-25
ES2304538T3 (es) 2008-10-16
DE10255040A1 (de) 2004-06-03
CA2507110C (fr) 2012-07-10
CA2507110A1 (fr) 2004-06-10
KR20050086821A (ko) 2005-08-30
MXPA05005443A (es) 2005-08-03
NO20053089D0 (no) 2005-06-23
EP1567526A1 (fr) 2005-08-31
EP1567526B1 (fr) 2008-04-16
PL376638A1 (pl) 2006-01-09
ZA200502946B (en) 2005-11-23
DE50309655D1 (de) 2008-05-29
ATE392424T1 (de) 2008-05-15
CN1717408A (zh) 2006-01-04
AU2003289880A1 (en) 2004-06-18
BR0316549A (pt) 2005-10-04
ECSP055803A (es) 2005-08-11
WO2004048373A1 (fr) 2004-06-10
JP4754829B2 (ja) 2011-08-24

Similar Documents

Publication Publication Date Title
HRP20050465A2 (en) Carbamic acid esters with an anticholinergic action
MXPA04006677A (es) Procedimiento para la preparacion de esteres de escopina.
RS65604A (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
HRP20070560T3 (en) Dpp-iv inhibitors
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
SI1599478T1 (sl) Dihidropteridinoni, postopek za njihovo pripravo in njihova uporaba kot zdravila
DE50304569D1 (de) Xanthencarbonsäureester des tropenols und scopins als m3-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
RS20050719A (en) Novel diphenyl azetidinone with improved phzsiolo gical characteristics, corresponding production method, medicaments containing said compound and use of the latter
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
MY141020A (en) Novel pparalpha and ppargamma agonists
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
MXPA02012112A (es) Composiciones que contienen policarbonato.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
WO2003014094A3 (fr) Heterocyclylarylsulfonamides
EP1496077A4 (fr) Compose polyether contenant des groupes acide et insature, procede de production et composition de resine associes
YU52602A (sh) Postupak za pripremanje estara aril-iminometil-karbaminske kiseline
ATE399779T1 (de) Zwischenprodukte für die herstellung von neuraminidase-inhibitor-konjugaten
WO2004096829A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes-17-halogenes
WO2004041830A3 (fr) Procede ameliore de preparation de biotine
WO2001010862A3 (fr) Heterocyclybenzofuranes substitues
MXPA05008862A (es) Heterociclos de nitrogeno n-arilo sustituidos.
IL164437A0 (en) Method for the production of 2,4,5-trimethylphenylacetic acid
MXPA03010325A (es) Benzoilciclohexenonas substituidas y su uso como agentes herbicidas.
HRP20050791A2 (en) Nitrate esters of phenylaminothiophenacetic acid derivatives
TWI256385B (en) Method and intermediate for preparing a prostaglandin f-type compound

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20071114

Year of fee payment: 5

OBST Application withdrawn